Page last updated: 2024-11-05

tetraethoxysilane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Tetraethoxysilane, also known as TEOS, is a colorless liquid used as a precursor in the synthesis of silicon-based materials. It is a highly reactive compound that readily hydrolyzes to form silica, a versatile material with applications in various fields, including glass production, ceramics, electronics, and coatings. TEOS's importance stems from its ability to be easily converted into silica, a crucial material for various technological advancements. The hydrolysis reaction of TEOS is highly sensitive to factors such as pH, temperature, and the presence of catalysts. Researchers investigate the properties and reactions of TEOS to improve the synthesis of silica-based materials with enhanced performance and applications.'

Cross-References

ID SourceID
PubMed CID6517
CHEMBL ID3187981
SCHEMBL ID17680
MeSH IDM0121130

Synonyms (87)

Synonym
etylu krzemian
tetraethoxysilicon
ethyl silicate, ((eto)4si)
silicate d'ethyle
silicate tetraethylique
ethyl orthosilicate
nsc4790
wln: 2o-si-o2&o2&o2
nsc-4790
silicic acid (h4sio4), tetraethyl ester
silicic acid, tetraethyl ester
teos
tetraethoxysilane
dynasil a
tetraethyl silicate
78-10-4
silicon ethoxide
es 28 ester
silicon tetraethoxide
tetraethyl orthosilicate
silane, tetraethoxy-
ethyl silicate
es 28
un1292
teos (van)
ai3-15098
etylu krzemian [polish]
silicate d'ethyle [french]
tetraethyl-o-silicate
silicate tetraethylique [french]
es 100
es 28 (ester)
orthosilicic acid, tetraethyl ester
einecs 201-083-8
silikan l
nsc 4790
hsdb 534
brn 1422225
tetraethylsilikat [czech]
silicic acid, (h4sio4), tetraethyl ester
tetraethyl orthosilicate, reagent grade, 98%
tetraethyl orthosilicate, 99.999% trace metals basis
tetraethyl orthosilicate, >=99.0% (gc)
botdanwdwhjenh-uhfffaoysa-
inchi=1/c8h20o4si/c1-5-9-13(10-6-2,11-7-3)12-8-4/h5-8h2,1-4h3
AKOS000269012
FT-0655785
T0100
NCGC00248607-01
tetraethyl silicate [un1292] [flammable liquid]
tetraethylsilikat
ec 201-083-8
42064kre49 ,
ccris 8482
unii-42064kre49
tetraethylorthosilicate
tox21_200426
NCGC00257980-01
dtxcid906450
cas-78-10-4
dtxsid6026450 ,
1,2,3,4-tetrahydro-naphthalen-2-ylaminehydrochloride
S15425
tetraethyl orthosilicate [inci]
teos [van]
tetraethyl silicate [hsdb]
ethyl silicate [mi]
orthosilicic acid tetraethyl ester
tetraethoxysilicon(iv)
SCHEMBL17680
tetra(ethoxy)silane
si(oc2h5)4
tetraethylortho silicate
tetraethoxy silane
si(oet)4
STR05461
CHEMBL3187981
(c2h5o)4si
un 1292
mfcd00009062
F0001-2050
tetraethyl orthosilicate, packaged for use in deposition systems
tetraethyl orthosilicate, saj first grade, >=95.0%
Q421458
silicic acid,ethyl ester
tetraethyl-ortho-silicate
EN300-19960

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These acute toxic changes were dose and time dependent, but significant sex differences were not observed."( Acute urinary tract toxicity of tetraethylorthosilicate in rats.
Cano, M; Cohen, SM; Garland, EM; Johansson, SL; Johnson, LS; Okamura, T, 1992
)
0.28

Bioavailability

ExcerptReferenceRelevance
"Two experiments were conducted using completely randomized designs to study the bioavailability of Si from three sources to growing rats and turkeys fed semipurified diets."( Silicon bioavailability studies in young rapidly growing rats and turkeys fed semipurified diets: a comparative study.
Jia, X; Kayongo-Male, H, 1999
)
0.3

Dosage Studied

ExcerptRelevanceReference
" The coagulation results show that, in acidic conditions, the best dosage range of the flocculants with APDES as silicon source is the widest of the three, resulting in the best coagulation efficiency."( [Species distribution and coagulation behavior of covalent bonded aluminum-silicon hybrid flocculants].
Peng, JX; Zhao, HZ, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency69.84710.000221.22318,912.5098AID743054
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency31.19950.003041.611522,387.1992AID1159552
thyroid stimulating hormone receptorHomo sapiens (human)Potency69.84710.001628.015177.1139AID1224895
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (315)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (2.86)18.7374
1990's14 (4.44)18.2507
2000's103 (32.70)29.6817
2010's169 (53.65)24.3611
2020's20 (6.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.89 (24.57)
Research Supply Index5.77 (2.92)
Research Growth Index5.25 (4.65)
Search Engine Demand Index104.20 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (62.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other321 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]